Tumor suppression by either downregulation or upregulation of key transcriptional signals is well established in PCa, where both androgen deprivation and supraphysiological doses of testosterone (SupraT) suppress the growth of cancers with canonical AR signaling, the basis of bipolar androgen therapy (68). The gene discussed is AR; the disease is posterior cortical atrophy.